2025-12-14 216.73.216.3
Code of China Chinese Classification Professional Classification ICS Classification Latest News Value-added Services

Position: Chinese Standard in English/T/CQAP 3015-2025
T/CQAP 3015-2025   Specification for production and quality control of human mesenchymal stem cell drugs (English Version)
Standard No.: T/CQAP 3015-2025 Status:valid remind me the status change

Email:

Target Language:English File Format:PDF
Word Count: Translation Price(USD): remind me the price change

Email:

Implemented on:2025-11-10 Delivery:

→ → →

,,2025-11-10,20E437FD94CC4C761765623711596
Standard No.: T/CQAP 3015-2025
English Name: Specification for production and quality control of human mesenchymal stem cell drugs
Chinese Name: 人间充质干细胞药品生产和质量控制规范
Chinese Classification: C27    Biological agent and blood products
Professional Classification: T/    Social Organization Standard
ICS Classification: 11.120.10 11.120.10    Medicaments 11.120.10
Source Content Issued by: China Population Culture Promotion Association
Issued on: 2025-07-10
Implemented on: 2025-11-10
Status: valid
Target Language: English
File Format: PDF
本文件规定了人间充质干细胞(hMSC)药品生产和质量控制的总体要求,人员与培训,厂房设施与设备,生产用物料,目标产品质量概况,生产工艺,质量控制,稳定性考察,标签、说明书、包装、运输和贮存,质量风险管理,质量保证,持续改进。
本文件适用于注册临床试验和商业化阶段的异体hMSC药品生产和质量控制,自体来源hMSC产品、基因编辑或修饰的hMSC产品可以根据产品特性,经评估后参考本文件相关内容。
Code of China
Standard
T/CQAP 3015-2025  Specification for production and quality control of human mesenchymal stem cell drugs (English Version)
Standard No.T/CQAP 3015-2025
Statusvalid
LanguageEnglish
File FormatPDF
Word Count words
Price(USD)
Implemented on2025-11-10
Deliveryvia email in business day
Detail of T/CQAP 3015-2025
Standard No.
T/CQAP 3015-2025
English Name
Specification for production and quality control of human mesenchymal stem cell drugs
Chinese Name
人间充质干细胞药品生产和质量控制规范
Chinese Classification
C27
Professional Classification
T/
ICS Classification
Issued by
China Population Culture Promotion Association
Issued on
2025-07-10
Implemented on
2025-11-10
Status
valid
Superseded by
Superseded on
Abolished on
Superseding
Language
English
File Format
PDF
Word Count
words
Price(USD)
Keywords
T/CQAP 3015-2025, T/CQAPT 3015-2025, TCQAPT 3015-2025, T/CQAP3015-2025, T/CQAP 3015, T/CQAP3015, T/CQAPT3015-2025, T/CQAPT 3015, T/CQAPT3015, TCQAPT3015-2025, TCQAPT 3015, TCQAPT3015
Introduction of T/CQAP 3015-2025
本文件规定了人间充质干细胞(hMSC)药品生产和质量控制的总体要求,人员与培训,厂房设施与设备,生产用物料,目标产品质量概况,生产工艺,质量控制,稳定性考察,标签、说明书、包装、运输和贮存,质量风险管理,质量保证,持续改进。
本文件适用于注册临床试验和商业化阶段的异体hMSC药品生产和质量控制,自体来源hMSC产品、基因编辑或修饰的hMSC产品可以根据产品特性,经评估后参考本文件相关内容。
Contents of T/CQAP 3015-2025
About Us   |    Contact Us   |    Terms of Service   |    Privacy   |    Cancellation & Refund Policy   |    Payment
Tel: +86-10-8572 5655 | Fax: +86-10-8581 9515 | Email: coc@codeofchina.com | QQ: 672269886
Copyright: Beijing COC Tech Co., Ltd. 2008-2040
 
 
Keywords:
T/CQAP 3015-2025, T/CQAPT 3015-2025, TCQAPT 3015-2025, T/CQAP3015-2025, T/CQAP 3015, T/CQAP3015, T/CQAPT3015-2025, T/CQAPT 3015, T/CQAPT3015, TCQAPT3015-2025, TCQAPT 3015, TCQAPT3015